UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 1 filers reported holding UNIQURE NV in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,889,576 | -35.7% | 281,606 | +6.5% | 0.56% | -9.4% |
| Q2 2023 | $2,939,438 | -51.6% | 264,338 | -12.3% | 0.62% | -69.6% |
| Q1 2023 | $6,068,142 | -11.2% | 301,298 | 0.0% | 2.04% | -21.3% |
| Q4 2022 | $6,830,426 | +59.5% | 301,298 | +26.1% | 2.59% | +66.5% |
| Q3 2022 | $4,283,000 | -50.2% | 238,998 | -48.2% | 1.56% | -45.4% |
| Q2 2022 | $8,604,000 | -3.5% | 461,589 | -6.4% | 2.85% | +44.7% |
| Q1 2022 | $8,913,000 | -9.1% | 493,229 | +4.9% | 1.97% | +1.3% |
| Q4 2021 | $9,810,000 | – | 470,033 | – | 1.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |